 |
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|||
|
|
|||
|
|
|||
|
|||
Título originalAdjuvant Goserelin in Pre-Menopausal Patients with Early Breast Cancer: Results from the ZIPP Study |
Título en castellano Goserelín Adyuvante en Mujeres Premenopáusicas con Cáncer de Mama Temprano: Resultados del Estudio ZIPP |
||
|
Palabras clave goserelín, quimioterapia adyuvante, cáncer de mama precoz, premenopausia, Ablación ovárica |
Key Words Ovarian ablation, goserelin, early breast cancer, pre-menopausal, adjuvant chemotherapy |
||
|
Autores Baum M, Hackshaw A, Houghton J |
Dirigir correspondencia a: R Sainsbury, Department of Surgery, Institute of Surgical Studies, University College London W1W 7EJ Londres Reino Unido |
||
|
Patrocinio Grant from the CRUK. In Italy, the coordination of the trial was supported by an educational grant from AstraZeneca. |
Conflicto de interés Los autores no manifiestan conflictos de interés |
||
InstituciónDepartment of Surgery, Institute of Surgical Studies, University College London |
|||
|
ReSIIC editado en las
especialidades: |
|||
|
|
|
|
|
Sociedad Iberoamericana de Información Científica (SIIC)
|
EL GOSERELIN PROLONGA LA SUPERVIVENCIA EN PREMENOPAUSICAS CON CANCER DE MAMA TEMPRANO
Exclusivo
suscriptores/ assinantes 
